Automated Cell Counter Market Report 2025

This Automated Cell Counter market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The automated cell counter market size has grown strongly in recent years. It will grow from $5.42 billion in 2024 to $5.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increased awareness, advancements in diagnostic techniques, environmental factors, antifungal resistance, population growth, and immune compromised populations.

The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to regulatory support, environmental concerns, antimicrobial resistance, an aging population, precision medicine, global healthcare spending, infectious disease outbreaks, research funding, accessibility, and affordability. Major trends in the forecast period include regulatory support for innovation, expansion of the biopharmaceutical sector, increasing research activities, global healthcare infrastructure development, a shift towards remote monitoring, and a and a rise in point-of-care testing.

The increasing adoption of personalized medicine is set to drive the growth of the automated cell counter market. Personalized medicine tailors medical treatments to individual patient characteristics, often considering genetic, environmental, and lifestyle factors. This trend is growing due to advancements in genetic research and technology, enabling more precise treatments based on patients' unique profiles. Automated cell counting plays a vital role in personalized medicine by rapidly and accurately analyzing patient-specific cell populations, aiding in the customization of treatments according to individual cellular profiles. For example, the FDA approved 16 new personalized treatments for rare disease patients in February 2024, a significant increase from the 6 approvals in 2022, as reported by the Personalized Medicine Coalition (PMC). This uptrend in personalized medicine adoption will be a key driver for the automated cell counter market's growth.

Leading companies in the automated cell counter market are concentrating on incorporating intelligent algorithms and machine learning, such as the AI automated cell culture system, to streamline and automate cell growth and scalability processes in biological research and biomanufacturing. An AI-automated cell culture system utilizes artificial intelligence to monitor, manage, and optimize cell growth and maintenance autonomously in laboratory settings. For instance, Molecular Devices LLC introduced the CellXpress.ai automated cell culture system in October 2023, featuring machine learning-powered software that simplifies complex cell culture processes. This system integrates an incubator, liquid handler, and imager to automate feeding and passaging schedules, giving scientists more efficiency and control in the lab.

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition aims to strengthen Cell Microsystems' capabilities in cellular analysis by incorporating Fluxion Biosciences' advanced patch clamp technology and assay tools. Fluxion Biosciences, also based in the US, specializes in developing automated systems and tools for cell-based assays and electrophysiology.

Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.

North America was the largest region in the automated cell counter market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the automated cell counter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An automated cell counter is a specialized instrument used in laboratory settings to rapidly and accurately count cells within a biological sample. These instruments employ advanced optical or electronic technologies to automate the cell counting process, eliminating the need for manual counting under a microscope.

The main types of products in an automated cell counter include consumable accessories and instruments. Consumables and accessories in automated cell counting comprise items such as reagents, calibration standards, and disposable slides or microplates, crucial for conducting cell counting procedures accurately and efficiently. These products find applications in various areas such as blood analysis, urine analysis, microbial cell count, cell line viability assessment, and others. End users of automated cell counters include pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, research institutes, and others.

The automated cell counter market research report is one of a series of new reports that provides automated cell counter market statistics, including automated cell counter industry global market size, regional shares, competitors with an automated cell counter market share, detailed automated cell counter market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell counter industry. This automated cell counter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated cell counter market consists of revenues earned by entities by providing services such as instrument installation, maintenance, technical support, training programs, cell counting processes and customization options. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated cell counter market also includes sales of flow cytometers, image-based cell counters, electrical impedance Coulter counters, reagents, calibration standards, and disposable slides or microplates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.